Download PDF

Price: $0
No charge, funded by The Conference Board of Canada and/or the research sponsor

Biotechnology in Canada: A Technology Platform For Growth

The Conference Board of Canada, 58 pages, November 28, 2005
Report by ,
3.2/5 based on 4 reviews
(You must be signed in and entitled to rate this report)
Biotechnology is poised to affect Canada dramatically over the coming decade. This report analyzes what Canada's business, government and academic communities must do to help Canada's biotech sector compete successfully in the global marketplace.

Document Highlights

Canada needs to act quickly to capitalize on the opportunities presented by biotechnology—a sector whose importance to our economy will increase over the coming decade. Canada's past performance in biotechnology has been relatively strong, but that is no guarantee of future success. Looking forward, our ability to be global-best in biotechnology will require a more focused approach. We will need to establish an integrated biotechnology strategy that can encompass risk capital, highly skilled talent, and regulatory and policy changes, as well as capitalize on our emerging biotechnology assets and historic economic strengths. Success in biotechnology will require a global presence and a global approach. Biotechnology in Canada: A Technology Platform for Growth evaluates Canada's performance in biotechnology relative to that of other countries, and identifies the key issues that business, government and academia must address. Its purpose is to establish the foundation for a sophisticated, nuanced, ongoing discussion about biotechnology in Canada.

Download PDF

Price: $0
No charge, funded by The Conference Board of Canada and/or the research sponsor